158 related articles for article (PubMed ID: 19067787)
41. Diabetic peripheral neuropathy and prevalence of erectile dysfunction in Japanese patients aged <65 years with type 2 diabetes mellitus: The Dogo Study.
Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Maruyama K; Ueda T; Senba H; Todo Y; Torisu M; Minami H; Onji M; Tanigawa T; Matsuura B; Hiasa Y; Miyake Y
Int J Impot Res; 2017 Jan; 29(1):30-34. PubMed ID: 27784886
[TBL] [Abstract][Full Text] [Related]
42. Role of oxidative stress-induced systemic and cavernosal molecular alterations in the progression of diabetic erectile dysfunction.
Castela A; Gomes P; Domingues VF; Paíga P; Costa R; Vendeira P; Costa C
J Diabetes; 2015 May; 7(3):393-401. PubMed ID: 24910190
[TBL] [Abstract][Full Text] [Related]
43. Erectile dysfunction and diabetes: a review of the current evidence-based medicine and a synthesis of the main available therapies.
Phé V; Rouprêt M
Diabetes Metab; 2012 Feb; 38(1):1-13. PubMed ID: 22056307
[TBL] [Abstract][Full Text] [Related]
44. Prevalence and determinants of erectile dysfunction among people with type 2 diabetes in Ilorin, Nigeria.
Olarinoye JK; Kuranga SA; Katibi IA; Adediran OS; Jimoh AA; Sanya EO
Niger Postgrad Med J; 2006 Dec; 13(4):291-6. PubMed ID: 17203117
[TBL] [Abstract][Full Text] [Related]
45. Poly(ADP-Ribose) polymerase inhibition improves erectile function in diabetic rats.
Wan ZH; Li WZ; Li YZ; Chen L; Li GH; Hu WF; Peng S; Yu JJ; Guo F
J Sex Med; 2011 Apr; 8(4):1002-14. PubMed ID: 20807334
[TBL] [Abstract][Full Text] [Related]
46. Testosterone therapy in erectile dysfunction and hypogonadism.
Shabsigh R
J Sex Med; 2005 Nov; 2(6):785-92. PubMed ID: 16422803
[TBL] [Abstract][Full Text] [Related]
47. Antioxidant icariside II combined with insulin restores erectile function in streptozotocin-induced type 1 diabetic rats.
Wang L; Xu Y; Li H; Lei H; Guan R; Gao Z; Xin Z
J Cell Mol Med; 2015 May; 19(5):960-9. PubMed ID: 25781208
[TBL] [Abstract][Full Text] [Related]
48. Erectile dysfunction and dyslipidemia: relevance and role of phosphodiesterase type-5 inhibitors and statins.
Miner M; Billups KL
J Sex Med; 2008 May; 5(5):1066-1078. PubMed ID: 18331271
[TBL] [Abstract][Full Text] [Related]
49. Pathophysiology of erectile dysfunction.
Matsui H; Sopko NA; Hannan JL; Bivalacqua TJ
Curr Drug Targets; 2015; 16(5):411-9. PubMed ID: 25950641
[TBL] [Abstract][Full Text] [Related]
50. Is type 2 diabetes mellitus a cause of severe erectile dysfunction in patients with metabolic syndrome?
Aslan Y; Sezgin T; Tuncel A; Tekdogan UY; Guler S; Atan A
Urology; 2009 Sep; 74(3):561-4. PubMed ID: 19604566
[TBL] [Abstract][Full Text] [Related]
51. A comprehensive review of erectile dysfunction in men with diabetes.
Kamenov ZA
Exp Clin Endocrinol Diabetes; 2015 Mar; 123(3):141-58. PubMed ID: 25502583
[TBL] [Abstract][Full Text] [Related]
52. Stem Cell Therapy for Diabetic Erectile Dysfunction in Rats: A Meta-Analysis.
Li M; Li H; Ruan Y; Wang T; Liu J
PLoS One; 2016; 11(4):e0154341. PubMed ID: 27111659
[TBL] [Abstract][Full Text] [Related]
53. Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome.
Corona G; Forti G; Maggi M
Aging Male; 2008 Dec; 11(4):193-9. PubMed ID: 19172551
[TBL] [Abstract][Full Text] [Related]
54. PDE5 inhibitors: targeting erectile dysfunction in diabetics.
Francis SH; Corbin JD
Curr Opin Pharmacol; 2011 Dec; 11(6):683-8. PubMed ID: 21924956
[TBL] [Abstract][Full Text] [Related]
55. Diabetes, cardiovascular diseases and risk of erectile dysfunction: a brief narrative review of the literature.
Parazzini F; Ricci E; Chiaffarino F; Trinchieri A
Arch Ital Urol Androl; 2009 Mar; 81(1):24-31. PubMed ID: 19499755
[TBL] [Abstract][Full Text] [Related]
56. Erectile dysfunction in diabetes mellitus contributes to poor quality of life.
Avasthi A; Grover S; Bhansali A; Dash RJ; Gupta N; Sharan P; Sharma S
Int Rev Psychiatry; 2011; 23(1):93-9. PubMed ID: 21338304
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of erectile dysfunction among Saudi type 2 diabetic patients.
Hassan A; Aburisheh K; Sheikh TJ; Meo SA; Ahmed NA; Al Sharqawi AH
Eur Rev Med Pharmacol Sci; 2014; 18(7):1048-57. PubMed ID: 24763886
[TBL] [Abstract][Full Text] [Related]
58. Anatomy, physiology, and pathophysiology of erectile dysfunction.
Gratzke C; Angulo J; Chitaley K; Dai YT; Kim NN; Paick JS; Simonsen U; Uckert S; Wespes E; Andersson KE; Lue TF; Stief CG
J Sex Med; 2010 Jan; 7(1 Pt 2):445-75. PubMed ID: 20092448
[TBL] [Abstract][Full Text] [Related]
59. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes.
Kapoor D; Clarke S; Channer KS; Jones TH
Int J Androl; 2007 Dec; 30(6):500-7. PubMed ID: 18028199
[TBL] [Abstract][Full Text] [Related]
60. Sexual Dysfunction in Type 2 Diabetes at Diagnosis: Progression over Time and Drug and Non-Drug Correlated Factors.
Corona G; Giorda CB; Cucinotta D; Guida P; Nada E;
PLoS One; 2016; 11(10):e0157915. PubMed ID: 27706160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
